Over the Counter Drugs: The interface between self medication and the NHS

BMJ

Volumn 312, Issue 7032, 1996, Pages 688-

  Thomas, D Huw V ^a   Noyce, Peter R ^b  

^a St John's Health Centre   (Canada)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; BECLOMETASONE DIPROPIONATE; CIMETIDINE; CLOTRIMAZOLE; FAMOTIDINE; NON PRESCRIPTION DRUG; PARACETAMOL;

ALLERGIC RHINITIS; ARTICLE; DRUG COST; DRUG INFORMATION; DRUG USE; GENERAL PRACTITIONER; HERPES; HUMAN; NATIONAL HEALTH SERVICE; PATIENT REFERRAL; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; SELF MEDICATION; VAGINA CANDIDIASIS;

ATTITUDE OF HEALTH PERSONNEL; DRUG AND NARCOTIC CONTROL; DRUG COSTS; DRUGS, NON-PRESCRIPTION; FAMILY PRACTICE; GREAT BRITAIN; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PRESCRIPTIONS, DRUG; SELF MEDICATION;

EID: 85007703303     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7032.688     Document Type: Article

References (19)

1. PRISM (Progressive Research in Self-Medication) 94. London: Readers' Digest, 1994.
2. British Market Research Bureau. Everyday health care. A consumer study of self-medication in Great Britain. London: BMRB, 1987.
3. Thom C. Patient concern important in pharmacists' view on POM to P switches. Pharm J 1994; 253: 616.
4. Noyce PR. Rationalising the pharmacist's role. Int J Pharm Pract 1992; 1: 122–3.
5. Schafheutle EL. Deregulation of POM: decision-making and outcomes in patients treating a minor ailment. Manchester: University of Manchester, 1994. (MSc dissertation.)
6. Colwell J, Chansarkar B. Higher prescription charges—implications for pharmacists. Pharm J 1993; 251: 194–7.
7. Proprietary Association of Great Britain. OTC Directory 1995-6. London: PAGB, 1995.
8. UK GPs and self-medication: no conflict of interest? OTC Business News 1994 July 6: 13.
9. Bradley C. GPs' and patients' views on OTC self-medication. Prescriber 1995 March 5:75–7.
10. Ryan M, Yule B. Switching drugs from prescription-only to over-the-counter availability: economic benefits in the United Kingdom. Health Policy 1990; 16: 233–9.
11. Bahra MS, Alexander AM, Lowen N. Changes in the purchase and prescribing of intravaginal imidazoles since the reclassification from POM to P. Pharm J 1994; 253: R10.
12. Consumers' Association. Pharmacists: how reliable are they? Which? Way to Health 1991, December:191–4.
13. Rogers PJ, Fletcher G, Rees JE. Patient medication records in community pharmacy. Pharm J 1992; 248: 193–6.
14. Rogers PJ, Fletcher G, Rees JE. Clinical interventions by community pharmacists using patient medication records. Int J Pharm Pract 1994; 3: 6–13.
15. Noyce PR. How high street chemists could out NHS costs. Parliamentary Brief 1995; 3 5: 85–6.
16. Heath I. The creeping privatisation of NHS prescribing. BMJ 1994; 309: 623–4.
17. Head S. Privatisation of NHS prescribing. BMJ 1994; 309: 957.
18. Blenkinsopp A, Jepson MH, Drury M. Using a notification card to improve communication between community pharmacists and general medical practitioners. Br J Gen Pract 1991; 41: 116–8.
19. Termin P. Costs and benefits in switching drugs from Rx to OTC. J Health Econ 1983; 2: 187–205.